» Articles » PMID: 30575975

Gender Difference in Clinical Conditions Among Hospitalized Adults with Myotonic Dystrophy

Overview
Journal Muscle Nerve
Date 2018 Dec 22
PMID 30575975
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In this study we examined gender differences in adult hospitalizations with myotonic dystrophy (DM).

Methods: From the Nationwide Inpatient Sample (NIS) 2010-2014, we identified 1,891 adult hospitalizations with a DM diagnosis and constructed a comparison group of hospitalizations without DM using propensity score matching. We calculated relative risk by gender for 44 clinical diagnoses that each accounted for at least 5% of DM hospitalizations.

Results: Hospitalizations with DM were longer (4.8 vs. 4.1 days, P < 0.0001) and more costly ($13,241 vs. $11,458, P < 0.0001) than those without DM. More than half (25 of 44) of the conditions co-occurring with DM hospitalizations did not differ in their relative risks by gender. For those that differed by gender, only 5 were specific to DM, compared with hospitalizations without DM.

Discussion: Our findings highlight the importance of comprehensive and coordinated care for DM rather than gender-oriented care in the inpatient setting. Muscle Nerve 59:348-353, 2019.

Citing Articles

CNS involvement in myotonic dystrophy type 1: does sex play a role?.

Garmendia J, Labayru G, Aliri J, de Munain A, Sistiaga A Front Neurol. 2024; 15:1399898.

PMID: 38784913 PMC: 11111927. DOI: 10.3389/fneur.2024.1399898.

References
1.
Mah J, Korngut L, Fiest K, Dykeman J, Day L, Pringsheim T . A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies. Can J Neurol Sci. 2016; 43(1):163-77. DOI: 10.1017/cjn.2015.311. View

2.
Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B . Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol. 2017; 264(12):2472-2480. DOI: 10.1007/s00415-017-8653-2. View

3.
Das M, Moxley 3rd R, Hilbert J, Martens W, Letren L, Greene M . Correlates of tumor development in patients with myotonic dystrophy. J Neurol. 2012; 259(10):2161-6. PMC: 3469723. DOI: 10.1007/s00415-012-6476-8. View

4.
Dogan C, Antonio M, Hamroun D, Varet H, Fabbro M, Rougier F . Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality: A Nationwide Multiple Databases Cross-Sectional Observational Study. PLoS One. 2016; 11(2):e0148264. PMC: 4744025. DOI: 10.1371/journal.pone.0148264. View

5.
Hilbert J, Barohn R, Clemens P, Luebbe E, Martens W, McDermott M . High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2. Neurology. 2017; 89(13):1348-1354. PMC: 5649763. DOI: 10.1212/WNL.0000000000004420. View